The 18-month-old girl was found in a ‘critical condition’ inside the vehicle in Almada on the southern bank of the Tagus River directly opposite the capital Lisbon (Picture: Getty Images)
Wildfires have ravaged much of the UK and Europe this week,and southern Italy is no exception.
But authorities are now investigating whether the flames may have been spread deliberately – and in a ra
LAS VEGAS,Jan. 8,2025-- AIRSEEKERS,a revolutionary outdoor robotics technology company,showcased its Tronrobotic lawn mower at iMpact Connect. Made to simplify lawn care with unmatched precision,power
JAKARTA,Indonesia,Jan. 6,2025-- The Indonesian version of theaudiobook Namun Tetap Ada Rasa was successfully launched in Indonesia,quickly garnering enthusiastic responses from local readers and liste
BANGKOK,Jan. 6,2025-- The Thaiaudiobook series of The Grave Robbers\' Chronicles has officially launched on the Meb platform,receiving an enthusiastic response from readers. For Thai young adults and
DALIAN,China,Jan. 6,2025-- CBAK Energy Technology,Inc. (NASDAQ: CBAT) ("CBAK Energy" or the "Company"),a leading manufacturer of lithium-ion and sodium-ion batteries,as well as ele
SEOUL,South Korea,Jan. 7,2025-- KYUHYUN\'s Kaohsiung concert on Jan. 4 ― marking the first overseas show of his "COLORS" Asia tour ― ended with a bang,building high anticipation for his up
HONG KONG,Jan. 7,2025-- Eyebright Medical Technology (Beijing) Co.,Ltd. ("Eyebright Medical",the "Company",Stock Code: 688050.SH,together with its subsidiaries collectively known
01-08 Eyebright Medical Technology (Beijing) Co., Ltd.
TSUKUBA,Japan,Jan. 7,2025-- Researchers at the Research Center for Materials Nanoarchitectonics (MANA) have proposed a method to create ferroelectric-ferromagnetic materials,opening doors to advancing
01-08 Research Center for Materials Nanoarchitectonics (MANA), National Institute for Materials Science (NIMS)
BEIJING,Jan. 7,2025-- Baijiayun Group Ltd ("Baijiayun" or the "Company") (NASDAQ: RTC),a one-stop AI video solution provider,today announced that it had received a customer thank-y
TOURS,France,Jan. 7,2025-- GORTEC,known as Head and Neck Radiation Oncology Group,today announced that the randomized Phase 3 NIVOPOSTOP GORTEC 2018-01 trial evaluating nivolumab,Bristol Myers Squibb